ICM EVIDENCE FOR AF MANAGEMENT
Studies of insertable cardiac monitor use in atrial fibrillation management
Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
Studies of insertable cardiac monitor use in atrial fibrillation management
Reveal™ ICM Detects AF Burden Correctly 98% of the Time1
Relevance of Asymptomatic Arrhythmia Recurrence2
Prospective study of 114 AF-ablation patients followed by 7-day Holter before ablation, right after ablation, and after 3, 6, and 12 months of follow-up.
“Even in patients presenting with highly symptomatic AF, asymptomatic episodes may occur and significantly increase after catheter ablation. A symptom-only-based follow-up would substantially overestimate the success rate.”
More Patients Properly Detected and More Decisions Made with Reveal ICM3
More patients discontinue AADs with Reveal™ insertable cardiac monitoring
Majority of Patients Had NOAF; ILR Needed to Detect AF4